Diagnostic and prognostic value of brain natriuretic peptide (BNP) concentrations in very elderly heart disease patients: Specific geriatric cut-off and impacts of age, gender, renal dysfunction, and nutritional status

Archives of Gerontology and Geriatrics

Volumn 52, Issue 1, 2011, Pages 106-110

  Blonde Cynober F ^a   Morineau, G ^a   Estrugo, B ^a   Fillie, E ^a   Aussel, C ^a   Vincent, J P ^a  

^a Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

Brain natriuretic peptide (BNP); Geriatric nutritional risk index (GNRI); Heart failure; Renal function in elderly

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; AGED; ARTICLE; COCKROFT GAULT FORMULA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPNEA; ECHOGRAPHY; FEMALE; GERIATRIC NUTRITIONAL RISK INDEX; GERIATRIC PATIENT; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; KIDNEY DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SEX FACTORS; STATISTICS, NONPARAMETRIC; STROKE VOLUME;

EID: 78649706089     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2010.02.010     Document Type: Article

References (43)

1. Badgett R.G., Lucey C.R., Mulrow C.D. Can the clinical examination diagnose left-sided heart failure in adults?. J. Am. Med. Assoc. 1997, 277:1712-1719.
2. Bahlla M.A., Chiang A., Epshteyn V.A., Kazanegra R., Bhalla V., Clopton P., Krishnaswamy P., Morrison L.K., Chiu A., Gardetto N., Mudaliar S., Edel-man S.V., Henry R.R., Maisel A.S. Prognosis role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2004, 44:1047-1052.
3. Bouillanne O., Morineau G., Dupont C., Coulombel I., Vincent J.P., Nicolis I., Benazeth S., Cynober L., Aussel C. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am. J. Clin. Nutr. 2005, 82:777-783.
4. Breidthardt T., Laule K., Strohmeyer A.H., Schindler C., Meier S., Fischer M., Scholer A., Noveanu M., Christ M., Perruchoud A., Mueller C. Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin. Chem. 2007, 53:1415-1422.
5. Campbell K.H., O'Hare A.M. Kidney disease in the elderly: update on recent literature. Curr. Opin. Nephrol. Hypertens. 2008, 17:298-303.
6. Cheng B.S., Kazanagra R., Garcia A., Lenert L., Krishnaswamy P., Gardetto N., Clopton P., Maisel A. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J. Am. Coll. Cardiol. 2001, 37:386-391.
7. Chumlea W.C., Roche A.F., Steinbaugh M.L. Estimating stature from knee height for persons 60 to 90 years of age. J. Am. Geriatr. Soc. 1985, 33:116-120.
8. Codognotto M., Piccoli A., Zaninotto M., Mion M., Plebani M., Vertolli U., Tona F., Ruzza L., Barchita A., Boffa G.M. Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies. Clin. Chem. 2007, 53:2097-2104.
9. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., Jacobsen S.J., Heublein D.M., Burnett J.C. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. J. Am. Coll. Cardiol. 2006, 47:345-353.
10. Dao Q., Krishnaswamy P., Kazanegra P., Harrison A., Amirnovin R., Lenert L., Alberto J., Hlavin A., Maisel A.S. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J. Am. Coll. Cardiol. 2001, 37:379-385.
11. DeFilippi C.R., Seliger S.L., Maynard S., Christenson R.H. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin. Chem. 2007, 53:1511-1519.
12. DeFilippi C.R., Van Kimmenade R.R., Pinto Y.M. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am. J. Cardiol. 2008, 101:82-88.
13. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 2001, 345:1014-1021.
14. Dessi-Fulgheri P., Sarzani R., Serenelli M., Tamburrini P., Spagnolo D., Giantomassi L., Espinosa E., Rappelli A. Low caloric diet enhances renal, hemodynamic and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999, 33:658-662.
15. Fischer Y., Filzmaier K., Stiegler H., Graf J., Fuhs S., Franke A., Janssens U., Gressner A.M. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin. Chem. 2001, 47:591-594.
16. Giannessi D., Andreassi M.G., Del Ry S., Clerico A., Colombo M.G., Dini N. Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. J. Endocrinol. Invest. 2001, 24:8-16.
17. Giannessi D., Colotti C., Maltinti M., Del Ry S., Prontera C., Turchi S., L'Abbate A., Neglia D. Circulating heat chock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 2007, 12:265-274.
18. Haute Autorité de Santé, 2007. Recommandations professionnelles. Stratégie de prise en charge en cas de dénutrition protéinoénergétique chez la personne âgée. (in French). http://www.has-sante.fr/portail/jcms/c_546549.
19. Howie J.N., Caldwell M.A., Dracup K. The measurement of brain natriuretic peptide in heart failure. AACN Clin. Issues 2003, 14:520-531.
20. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., Antman E.M., Smith S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., Riegel B. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005, 112:e154-e235. American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society.
21. Jourdain P., Jondeau G., Funck F., Gueffet P., Le Helloco A., Donal E., Aupetit J.F., Aumont M.C., Galinier M., Eicher J.C., Cohen-Solal A., Juillière Y. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J. Am. Coll. Cardiol. 2007, 49:1733-1739.
22. Koseki Y., Watanabe J., Shinozaki T., Sakuma M., Komaru T., Fukuchi M., Miura M., Karibe A., Kon-no Y., Namaguchi H., Ninomiya M., Kagaya Y., Shirato K. Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan. Chronic Heart Failure Analysis Registry in Tohoku District (CHART). Circ. J. 2003, 67:431-436. CHART Investigators.
23. Kuster G.M., Tanner H., Printzen G., Suter T.M., Mohacsi P., Hess O.M. B-type natriuretic peptide for diagnosis and treatment of congestive hear disease. Swiss Med. Wkly. 2003, 133:623-628.
24. Lam C.S., Burnett J.C., Costello-Boerrigter L., Rodeheffer R.J., Redfield M.M. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J. Am. Coll. Cardiol. 2007, 49:1193-11202.
25. Levin E.R., Gardner D.G., Samson W.K. Mechanisms of disease: natriuretic peptides. N. Engl. J. Med. 1998, 339:321-328.
26. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., Maisel A.S. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Circulation 2002, 105:595-601.
27. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H.B., Clopton P., Steg P.G., Westheim A., Wold Knudsen C., Perez A., Kazanegra R., Herrmann H.C., McCullough P.A. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002, 347:161-167.
28. McLean A.S., Huang S.J., Nalos M., Tag B., Stewart D.E. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically-ill patients. Crit. Care Med. 2003, 31:2611-2618.
29. Mehra M.R., Uber P.A., Park M.H., Scott R.L., Ventura H.O., Harris B.C., Frohlich E.D. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J. Am. Coll. Cardiol. 2004, 43:1590-1595.
30. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A. Utility of a rapid B-natriuretic assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J. Am. Coll. Cardiol. 2002, 39:202-209.
31. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., Pfisterer M., Perruchoud A. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 2004, 350:647-654.
32. Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin. Chem. 2007, 53:552-574. NACB Writing Group Members, NACB Committee, National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Members.
33. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro-brain natriuretic peptide in a large sample of the general population. Heart 2003, 89:745-751.
34. Raynaud-Simon A. Dénutrition de la personne âgée: épidémiologie et conséquences. Traité de nutrition de la personne âgée 2009, 166-174. Springer, Paris, (in French). X. Hébuterne, E. Alix, A. Raynaud-Simon, B. Vellas (Eds.).
35. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoany D.W., Bailey K.R., Burnett J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 2002, 40:976-982.
36. Ritz P. Validity of measuring knee-height as an estimate of height in diseased French elderly persons. J. Nutr. Health Aging 2004, 8:386-388.
37. Sarzani R., Paci V.M., Zingaretti C.M., Pierleoni C., Cinti S., Cola G., Rappelli A., Dessi-Fulgheri P. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J. Hypertens. 1995, 13:1241-1246.
38. Sayama H., Nakamura Y., Saito N., Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?. Coron. Artery Dis. 1999, 10:537-540.
39. Sayama H., Nakamura Y., Saito N. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000, 46:71-77.
40. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., Hoes A., Jaarsma T., Korewicki J., Levy O.A., Linde C., Lopez-Sendon J.L., Nieminen M.S., Pierard L., Remme W.J. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J. 2005, 26:1115-1140.
41. Tang W.H.W., Girod J.P., Lee M.J., Starling R.C., Young J.B., Van Lente F., Francis G.S. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003, 108:2964-2966.
42. Ueda R., Yokouchi M., Suzuk T., Otomo E., Katagiri T. Prognostic value of plasma natriuretic peptide concentrations in very elderly persons. Am. J. Med. 2003, 114:266-270.
43. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W.F., Vasan R.S. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600.